In general, the participants in the CTX group were more likely to have hypertriglyceridemia [2.32 (1.68, 3.64) vs. 1.79 (1.21, 2.20), P = 0.002] and had higher PLA2R-CTLD678 IgG4 levels [7.21 (6.00, 7.97) vs. 5.96 ± 2.48, P = 0.024],compared with the RTX group. This evidence concerns the gene PLA2R1 and hypertriglyceridemia.